Czy ktoś z Was szczepił tutaj swoją pociechę na pneumokoki????
Proszę o Wasze info na ten temat, tzn. jakie są skutki po szczepionce i jak w ogóle lekarze podchodzą do tej sprawy.

Cytuj z: "Lucius"

Czy ktoś z Was szczepił tutaj swoją pociechę na pneumokoki????
Proszę o Wasze info na ten temat, tzn. jakie są skutki po szczepionce i jak w ogóle lekarze podchodzą do tej sprawy.

Wedlug artykulow w prasie szczepionka jest bezpieczna i uzywana jest w ramach szczepien podstawowych w wielu krajach jak: Australia, Belgia, Kanada, Francja, Niemcy, Grecja, Wlochy, Kuwejt, Luxembourg, Meksyk, Holandia, Norwegia, Katar, Szwajcaria, USA, UK (ostatnio wprowadzono w Irladnii Polnocnej). Szczepionka zalecana jest przez Swiatowa Organizacje Zdrowia (WHO). Szczepionka niedlugo ma wejsc do kalendarza szczepien w Irlandii. Lobbying odnosnie wprowadzenia szczepionki w IE prowadzi The Meningitis Trust, zalozony w latach 80-tych przez rodzicow dzieci, ktore zlapaly infekcje pneumokokowa. Zapytaj swego GP, na pewno maja juz te szczepionke (Prevenar produkowany przez Wyeth) albo moze ja zamowic dla ciebie. Na pewno dostal/a ulotke z Wyeth, ktora informuje jak dopasowac czas podania tej szczepionki do kalendarza szczepien w Irlandii. Wielka Brytania przy wprowadzaniu szczepionki podala te wytyczne (catch-up programme), ktore znajdziesz tu. Cytuje fragment:

Children under 12 months of age require two doses of PCV ( Pneumococcal vaccine), two months apart, followed by a dose at 13 months. Children aged between 12 and 24 months should be offered a single dose of PCV. Children aged over 24 months do not require vaccination.

Wiecej na temat wprowadzania szczepien w Irlandii z artykulow z prasy:

New vaccines to be offered to children
Dr Muiris Houston, Medical Correspondent, Irish Times, Friday, April 6, 2007

An expert committee is set to recommend significant changes to the Republic's childhood immunisation scheme, The Irish Times has learned.

Vaccines against pneumococcal disease, a bacteria that causes meningitis and pneumonia, and against hepatitis B, a virus that can lead to liver failure, are to be included in the universal immunisation scheme available free to all children in the State.

The National Immunisation Advisory Committee (NIAC) of the Royal College of Physicians in Ireland is about to advise the Department of Health that the risk to public health from these diseases is such that preventive vaccination is now required.

The Minister for Health, Mary Harney, has told the Dáil that she and the Health Service Executive (HSE) "will be guided by the expert advice from the NIAC".

However, it could be some time before the new schedule will be implemented. Negotiations on fees will have to be agreed with the Irish Medical Organisation (IMO), representing the general practitioners who administer childhood vaccines. And the HSE will have to meet the significant costs of the new vaccines, with the pneumococcal vaccine alone costing in the region of €70 for each shot.

The addition of the new vaccines will mean that infants will still get two injections at two months and four months: a new six-in-one injection (including hepatitis B) with a pneumococcal injection given at two months and a vaccine against meningitis C given at four months. Six-month-old infants will require three injections: the six-in-one, meningitis C and pneumococcal vaccinations. In addition, a booster pneumococcal vaccine will be required at 12 months. It will be given along with the MMR vaccine, with meningitis C and Hib (haemophilus influenzae B) boosters now given at 13 months.

Both hepatitis B and pneumococcus are killed (inactivated) vaccines and have a low incidence of side-effects. The infant pneumococcal vaccine has been widely used in Europe since 2001, while the hepatitis B vaccine has been part of childhood immunisation programmes in the US for some years. A separate pneumococcal vaccine has been available for older people and those at increased risk of infection.

There has been mounting pressure to introduce the pneumococcal vaccine, with the Meningitis Trust lobbying for its introduction for some time. The pneumococcal bug is the second most common cause of bacterial meningitis in the Republic, responsible for about one in 10 cases of the disease.

A report by the Health Protection Surveillance Centre, Invasive Pneumococcal Disease in Ireland, said there were 400 cases of the disease in the Republic in 2004. The highest incidence rates were found among older people and children aged under four.

The National Centre for Pharmaco-economics based at St James's Hospital, Dublin, recently carried out an economic valuation to assess the impact of introducing universal vaccination against pneumococcus. It concluded that when the effect of growing immunity against the bacteria in the population (the herd effect) was included, "a universal infant pneumococcal vaccination programme could be considered highly cost-effective in the Irish healthcare setting, from the perspective of the HSE".

Hepatitis B vaccination has been available for some time for healthcare workers and those travelling to areas where infection with the virus is endemic.

A high incidence of the disease among immigrants, coupled with increasing foreign travel by Irish people, are among the main reasons why the NIAC is about to recommend universal vaccination against hepatitis B.

The pneumococcal vaccine for infants is manufactured by the pharmaceutical company Wyeth. It is understood there are plans to begin making this at its facility in Clondalkin, Co Dublin, early next year.

Pneumococcal disease

Pneumococcal disease is caused by the bacterium streptococcus pneumoniae (also called pneumococcus).

It is a common cause of acute ear infection, infected sinuses, pneumonia and meningitis.

Pneumococcal disease occurs most commonly in the very young and in older people.

Others at increased risk of infection with the bacteria include those who have had their spleen removed and people with chronic kidney, liver or heart disease.

The microbe is surrounded by a capsule predominantly made up of complex sugars called polysaccharides.

With more than 90 different capsule types, it is the nature of the capsule that determines how infective each type of pneumococcus is.

The vaccine to be given to all infants contains polysaccharides from seven different capsule types, while that administered to older people has material from 23 types of capsule.

Globally, pneumococcal disease has been identified as the most important vaccine-preventable cause of death in children less than five years.

Vaccination has been shown to reduce the incidence of serious pneumococcal infection.

The new vaccine will be administered intramuscularly into the infant's thigh. It may cause a local reaction at the injection site or a transient fever. Irritability and drowsiness have also been reported.

Side effects such as seizures and allergic reactions are rare.  - Dr Muiris Houston

Pneumococcal vaccine looks set to be approved
By Sandra Ryan, Irish Medical Times, 23.03.2007
The vaccine to prevent pneumococcal disease will be approved by the National Immunisation Advisory Committee (NAIC) very soon, the Minister for Health, Mary Harney, has indicated.
During a discussion on patient safety legislation, at a meeting of the Oireachtas Joint Committee on Health and Children, the Minister said the NAIC is meeting at the end of March and she understands it will approve the vaccine.

The NAIC has been deliberating for five years on whether to introduce the vaccine, which has been available since 2000.

“I understand the next Committee meeting will be 21 March and I understand the vaccine will be approved,” said the Minister.

“In the rest of Europe the vaccine costs approximately €8 per shot and in Ireland it costs €35 per shot because of how we provide these vaccines. We would have the same issue with the cervical cancer vaccine; in many other countries it is administered by nurses. The greatest expense can often be the fee paid to the doctor, as it is in this case. We have a real issue in this regard.”

Health Minister Harney also said that discussions will have to take place with doctors representative bodies on the roll-out of more vaccines.

Vaccination backed by WHO

By Sandra Ryan, Irish Medical Times, 06.04.2007
The World Health Organ-ization (WHO) has announced its support for the introduction of a national immunisation programme worldwide to prevent pneumococcal disease.
“The WHO considers that it should be priority to include this vaccine in national immunisation programmes in view of the demonstrated efficacy of the vaccine,” said the WHO.

Ireland’s Meningitis Trust welcomed the move. “This is a boost to organisations such as Meningitis Trust who have been lobbying extensively for its introduction onto Ireland’s national immunisation programme,” said a spokeswoman for the trust. Children in the North are immunised with the vaccine to prevent life threatening illnesses such as pneumococcal meningitis, pneumonia and septicaemia while those in the Republic are not.

The vaccine, called Prevenar, is a part of the routine national childhood immunization schedule in Australia, Belgium, Canada, France, Germany, Greece, Italy, Kuwait, Luxembourg, Mexico, Netherlands, Norway, Qatar, Switzerland, the UK and the US.

The National Immunisation Committee met on the 21 March last but has not made any public announcement on whether it has decided to recommend the introduction of Prevenar onto the childhood immunisation schedule here, despite a statement from the Minister for Health, Mary Harney, that she believes the vaccine would be recommended.

It is estimated that 132 lives could be saved annually if routine immunisation against pneumococcal disease was undertaken in Ireland.

my szczepilismy Adama polska szczepionka Prevenar. nie bylo zadnych skutkow ubocznych. Lekarze i pl i irl stwierdzili ze mozna je powtarzac lub szczepic szczepionka Meningitis C ktora jest standartem w tutejszym kalendarzu szczepien.

dziękuję bardzo Wam za info. Ja swoją Juleczke będę szczepić w maju, także potem napisze co i jak. Z tego co mówił nam GP to za 2 lata ta szczepionka ma być już w tutejszym kalendarzu szczepień:)


[0] Indeks wiadomości